NEWSROOM

PRESS RELEASE

PRISM MarketView: Biotech In Motion – Lipella Pharmaceuticals Celebrates Year of Success

PRISM MarketView: Biotech In Motion – Lipella Pharmaceuticals Celebrates Year of Success

New York, December 20, 2023 - Clinical-stage biotechnology company, Lipella Pharmaceuticals (Nasdaq: LIPO) is celebrating a year of strategic accomplishments on its first anniversary as a public company. Lipella is advancing three clinical indications and has been granted two Orphan Drug Designations by the US Food and Drug Administration (FDA). https://prismmarketview.com/companies/lipella-pharmaceuticals-inc/ Today, the company announced it has successfully completed a Type C meeting with...

read more
Spooz, Inc. (SPZI) Completes Primary Acquisitions and Change of Control

Spooz, Inc. (SPZI) Completes Primary Acquisitions and Change of Control

Spooz Acquired Key JP Energy Assets; Vests Control to John K. Park Clearwater, FL., December 20, 2023 -- Spooz, Inc. (OTC: SPZI) completed the acquisition of key JP Energy assets for vesting control of Spooz, Inc. to John K. Park.  Additional assets to be announced later in exchange for vesting control of Spooz, Inc. to John K. Park. The first two companies announced as part of these acquisitions are JP Energy Group, Inc. (New Jersey Corporation) and JP Energy Global PTE, LTD (Singapore...

read more
Buy Now, Pay Later: Affirm Shares Jump on News of Walmart Partnership

Buy Now, Pay Later: Affirm Shares Jump on News of Walmart Partnership

New York, December 20, 2023 - Shares in payment network company, Affirm Holdings (Nasdaq: AFRM), jumped more than 15% on Tuesday after the company announced it would expand its partnership with Walmart to offer a Buy Now, Pay Later (BNPL) service at self-checkout kiosks at over 4,500 Walmart stores in the United States. https://prismmarketview.com/companies/affirm-holdings-inc/ https://prismmarketview.com/buy-now-pay-later-affirm-shares-jump-on-news-of-walmart-partnership/ Pat Suh, Affirm’s...

read more
Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished

Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished

-Lipella Granted Two Orphan Drug Designations by FDA- Pittsburgh, PA, December 20, 2023 - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) ("Lipella," "our," "us" or the "Company") a pioneering, clinical-stage pharmaceutical company, celebrates its first anniversary as a publicly traded entity. Based in Pittsburgh, PA, the Company has made substantial strides over the past year, achieving critical milestones and advancing its pipeline with three clinical indications and two orphan drug designations...

read more
SinglePoint Announces Closing of $4 Million Public Offering, Uplisting to Cboe Global Markets and Reverse Stock Split

SinglePoint Announces Closing of $4 Million Public Offering, Uplisting to Cboe Global Markets and Reverse Stock Split

Phoenix, AZ, December 19, 2023 - SinglePoint Inc. (Cboe: SING) (“SinglePoint” or the “Company”), a diversified holding company principally engaged through its subsidiaries in providing renewable energy solutions and energy-efficient applications to drive better health and living, today announced the closing of its underwritten public offering of 800,000 shares of common stock at a public offering price of $5.00 per share. The gross proceeds from the offering, before underwriting discounts...

read more
NRx Pharmaceuticals Secures IND for Urinary Tract Infection Treatment

NRx Pharmaceuticals Secures IND for Urinary Tract Infection Treatment

New York, December 19, 2023 - NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has been granted FDA clearance for its Investigational New Drug Application (IND) for NRX-101 for the treatment of complicated Urinary Tract infections (cUTI). The company’s shares surged 25% in trading on Monday following the news. https://prismmarketview.com/companies/nrx-pharmaceuticals-inc/ Complicated Urinary Tract Infections afflict approximately 3 million Americans each year, and pathogens have...

read more
PPJ Healthcare Enterprises, Inc. signed new Billing Accounts

PPJ Healthcare Enterprises, Inc. signed new Billing Accounts

TAMPA, FLORIDA, December 19, 2023 - PPJ Healthcare Enterprises Inc. (OTC Pink: PPJE) has announced today that it closed one billing agreement with a ‘pain management physicians’ group to provide their billing and collections. “We have been successful in providing specialty billing services for over 33 years, and we are very excited to add this group of physicians. The initial term of this agreement is two years. After taking time to sort out issues that held us back, the Company will now...

read more
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors

BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors

POMPANO BEACH, FLORIDA, December 19, 2023 - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces it has appointed Mr. Patrick Daly to its Board of Directors. Mr. Daly is an award-winning executive leader with a strong track record of success in operations, strategy, sales, marketing, fundraising, and partnership-building. BioStem...

read more
PRISM Analysis: Why Did Battalion Oil Shares Soar on Friday?

PRISM Analysis: Why Did Battalion Oil Shares Soar on Friday?

NEW YORK, NY, December 18, 2023 - Shares in Battalion Oil Corporation (NYSE American: BATL) surged more than 80% on Friday after the company announced it has agreed to be acquired by Fury Resources, Inc. for $9.80 per share in cash, which represents a total transaction value of approximately $450 million. The transaction is expected to close in the first quarter of 2024. https://prismmarketview.com/companies/trio-petroleum-corp/ Battalion’s CEO, Matt Steele, commented, “It has been a pleasure...

read more
MindMed Advances Treatment for Generalized Anxiety Disorder

MindMed Advances Treatment for Generalized Anxiety Disorder

NEW YORK, NY, December 18, 2023 - Biopharmaceutical company, Mind Medicine (Nasdaq: MNMD) has announced positive results from its Phase 2b clinical trial of MM-120 (lysergide d-tartrate) in generalized anxiety disorder (GAD). The trial met its primary endpoint, with MM-120 demonstrating statistically significant and clinically meaningful dose-dependent improvements. https://prismmarketview.com/companies/mind-medicine-mindmed-inc/ Robert Barrow, Chief Executive Officer and Director of MindMed,...

read more
SinglePoint Rings the Opening Bell at Cboe Global Markets Exchange

SinglePoint Rings the Opening Bell at Cboe Global Markets Exchange

Phoenix, AZ, December 18, 2023 - SinglePoint Inc. (Cboe: SING) (“SinglePoint” or the “Company”), a renewable solar energy and sustainable solutions provider participated in the iconic opening bell ringing ceremony, Friday December 15th, 2023. The event marked the successful listing of the Company’s common stock on the Cboe BZX Exchange. “It was a pleasure to initiate the Cboe opening bell in celebration of our listing,” said Ralston CEO SinglePoint Inc. “This marks a new era for...

read more
PRISM AdTech & Media Company Spotlight: Creative Realities Illuminates the Future of Experiential Design

PRISM AdTech & Media Company Spotlight: Creative Realities Illuminates the Future of Experiential Design

In the fast-paced landscape of experiential design and technology, Creative Realities Inc. seamlessly integrates the physical and digital realms in creating immersive experiences that captivate audiences across various industries. NEW YORK, NY, December 16, 2023 - Creative Realities specializes in interactive displays, immersive retail solutions, and cutting-edge content creation to reshape how individuals connect with brands and spaces. With a commitment to innovation and a client-centric...

read more
Rogue One Provides Corporate Update

Rogue One Provides Corporate Update

WASHINGTON, DC, December 15, 2023 -As many are aware, Rogue One, Inc. ("Company") has not submitted any financial statements subsequent to the Quarterly Report dated September 30, 2021. It is imperative to note that the recent action undertaken by the Securities and Exchange Commission on December 5, 2023, was not involuntary, but a result of a negotiated ‘Stipulation Letter' with the SEC which leads to revoking our 12G securities registration status. Consequently, Rogue One, Inc is no longer...

read more
PRISM MediaWire – Weekly Press Resume – Dec. 11 to Dec. 15, 2023

PRISM MediaWire – Weekly Press Resume – Dec. 11 to Dec. 15, 2023

New York, December 15, 2023 PRISM MediaWire - Weekly Press Resume Dec. 11 to Dec. 15, 2023 UAT Group Receives Financing for Iron Removal System https://prismmediawire.com/uat-group-receives-financing-for-iron-removal-system/ SKYX and GE Sign a Five-Year Renewal of a Global Licensing Master Service Agreement as SKYX Continues to Enhance its Market Penetration and Collaborations with U.S. and World Leading Strategic Companies...

read more
“Exceptional Result”: NeuroSense Therapeutics Reports New Positive Data from ALS Trial

“Exceptional Result”: NeuroSense Therapeutics Reports New Positive Data from ALS Trial

NEW YORK, NY, December 15, 2023 - NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) has reported additional positive efficacy data from its Phase 2b trial evaluating PrimeC, the company’s lead drug candidate for amyotrophic lateral sclerosis (ALS). The company’s share price rose nearly 30% in trading on Thursday. https://prismmarketview.com/companies/neurosense-therapeutics-ltd/ Alon Ben-Noon, NeuroSense’s CEO, commented, “As we analyze the PARADIGM trial results, we continue to gain a better...

read more
CORRECTION FROM SOURCE: SinglePoint, Inc. – The Inaugural US Company to List on Cboe BZX Exchange

CORRECTION FROM SOURCE: SinglePoint, Inc. – The Inaugural US Company to List on Cboe BZX Exchange

Correcting number of shares in previous Press Release SinglePoint, Inc. common stock to begin trading on Cboe BZX Exchange on December 15th, 2023, under the symbol “SING” Simultaneous capital raise of $4 Million Enable the Company to fully execute its national acquisition strategy and expand solar, battery, EV charging businesses Phoenix, AZ, December 15, 2023 - SinglePoint, Inc. (Cboe BZX: SING) ("SinglePoint" or "the Company"), a renewable solar energy and sustainable solutions provider,...

read more
CORRECTION FROM SOURCE: SinglePoint, Inc. – The Inaugural US Company to List on Cboe BZX Exchange

SinglePoint, Inc.–The Inaugural US Company to List on Cboe BZX Exchange

SinglePoint, Inc. common stock to begin trading on Cboe BZX Exchange on December 15th, 2023, under the symbol “SING” Simultaneous capital raise of $4 Million Enable the Company to fully execute its national acquisition strategy and expand solar, battery, EV charging businesses Phoenix, AZ, December 15, 2023 - SinglePoint, Inc. (Cboe BZX: SING) ("SinglePoint" or "the Company"), a renewable solar energy and sustainable solutions provider, announced today that its shares of common stock to begin...

read more
Verde Bio Holdings Announces Entry Into Business Combination Agreement with SensaSure Technologies, Inc.

Verde Bio Holdings Announces Entry Into Business Combination Agreement with SensaSure Technologies, Inc.

Transaction will provide Formation Minerals Inc., a wholly-owned subsidiary of SensaSure Technologies, Inc. (OTCQB: SSTC) the ability to be one of the first end to end platforms to build, run, manage, grow and monetize oil and gas mineral and royalty portfolios LAS VEGAS, NV and JACKSBORO, TX, December 15, 2023 – Verde Bio Holdings, Inc. (OTC: VBHI) (“Verde”), an emerging oil and gas royalty company, and SensaSure Technologies, Inc. (OTCQB: SSTC) (“SSTC”) today announced that Verde has entered...

read more
CORRECTION FROM SOURCE: SinglePoint, Inc. – The Inaugural US Company to List on Cboe BZX Exchange

SinglePoint Announces Pricing of $4 Million Public Offering, Uplisting to Cboe Global Markets and Reverse Stock Split

Phoenix, AZ, December 15, 2023 - SinglePoint Inc. formerly (OTC: SING) now trades as (Cboe: SING) (“SinglePoint” or the “Company”), a diversified holding company principally engaged through its subsidiaries in providing renewable energy solutions and energy-efficient applications to drive better health and living, today announced the pricing of its underwritten public offering of 800,000 shares of common stock at a public offering price of $5.00 per share. The gross proceeds from the...

read more
PRISM AdTech & Media Company Spotlight: Creative Realities Illuminates the Future of Experiential Design

PRISM AdTech & Media Company Spotlight: Creative Realities (CREX) Illuminates the Future of Experiential Design

NEW YORK, NY, December 14, 2023 - In the fast-paced landscape of experiential design and technology, Creative Realities Inc. ($CREX) seamlessly integrates the physical and digital realms in creating immersive experiences that captivate audiences across various industries. From transforming retail spaces into dynamic environments to utilizing cutting-edge technologies in interactive displays, CREX is reshaping the way we interact with the world....

read more
Center for Medicare Services Established National Pricing of AmnioWrap2 (TM) in All MAC Regions

Center for Medicare Services Established National Pricing of AmnioWrap2 (TM) in All MAC Regions

Pricing Provides AmnioWrap2TM Reimbursement in All MAC Regions POMPANO BEACH, FLORIDA, December 14, 2023 - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, announced that the Center for Medicare Services (CMS) has established national pricing for its product, AmnioWrap2TM, in all Medicare Administrative Contractors (MAC) regions. This pricing...

read more
Sono-Tek Announces Preliminary Record Revenue with Continued Strong Backlog for Q3 FY2024 and Increases Revenue Guidance for Fiscal Year 2024 

Sono-Tek Announces Preliminary Record Revenue with Continued Strong Backlog for Q3 FY2024 and Increases Revenue Guidance for Fiscal Year 2024 

- Sales Grew 58% YOY; Backlog Grew 68% YOY and Remains Strong at $10.4 Million; Company Projects 30% Revenue Growth for Fiscal Year ending February 29, 2024-  MILTON, NY, December 14, 2023 – Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced preliminary sales and backlog for the third quarter of fiscal year 2024, ended November 30, 2023.   •  Preliminary sales for the third quarter of FY2024 were...

read more
PRISM Oil & Gas: S&P Sets Fresh YTD High; Falling Gasoline Prices Play Key Role in Cooling Inflation

PRISM Oil & Gas: S&P Sets Fresh YTD High; Falling Gasoline Prices Play Key Role in Cooling Inflation

NEW YORK, NY, December 13, 2023 - US equities closed mostly higher on Tuesday as the S&P set a fresh year-to-date high, finishing the day at its highest level since January 2022, just 3.2% below its all-time high. Energy stocks underperformed while gasoline prices were down (6%) for the month, playing a key role in cooling inflation numbers for November. The S&P 500 Energy Index was down (1.35%) versus the S&P 500 which rose +0.14%. The XLE settled down (1.39%), the XOP fell...

read more
FDA Grants PMA Supplement Approval for ReShape Lifesciences Lap Band; Shares Surge 100%

FDA Grants PMA Supplement Approval for ReShape Lifesciences Lap Band; Shares Surge 100%

NEW YORK, NY, December 13, 2023 - ReShape Lifesciences (Nasdaq: RSLS) has been granted FDA approval of a PMA supplement for the company’s next generation, enhanced Lap-Band® 2.0 FLEX. The company’s share price surged 100% in trading on Wednesday morning. https://prismmarketview.com/companies/reshape-lifesciences-inc/ Paul F. Hickey, President and Chief Executive Officer of ReShape Lifesciences, said, “PMA supplement approval for our next generation Lap-Band® 2.0 FLEX is a...

read more
PRISM MarketView Biotech in Motion Spotlight: Quoin Receives FDA Clearance for Netherton Syndrome Clinical Optimization Plan

PRISM MarketView Biotech in Motion Spotlight: Quoin Receives FDA Clearance for Netherton Syndrome Clinical Optimization Plan

NEW YORK, NY, December 13, 2023 - Quoin Pharmaceuticals (Nasdaq: QNRX) has received U.S. Food and Drug Administration (FDA) clearance to implement several protocol amendments to its two ongoing clinical trials for QRX003, which is a potential treatment for Netherton Syndrome, a rare genetic skin disease for which there is no cure and no approved treatments. These protocol amendments are being implemented with a view to generating an even more robust data set and potentially more...

read more
Center for Medicare Services Established National Pricing of AmnioWrap2 (TM) in All MAC Regions

BioStem Technologies Bolsters Leadership with Appointment of Thomas Dugan to Board of Directors

POMPANO BEACH, FLORIDA, December 13, 2023 - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces the appointment of Mr. Thomas J. Dugan to the position of Chairman of the Board. Mr. Dugan brings a wealth of experience to BioStem, with proven, hands-on expertise as a senior executive who has transformed businesses, established new...

read more
GK Financing LLC, a Subsidiary of American Shared Hospital Services, Announces Agreement to Reload Lovelace Medical Center with New Cobalt Sources and Software Upgrade

GK Financing LLC, a Subsidiary of American Shared Hospital Services, Announces Agreement to Reload Lovelace Medical Center with New Cobalt Sources and Software Upgrade

Installation expected to be Completed in Mid-2024 SAN FRANCISCO, December 13, 2023 - GK Financing LLC (GKF), a subsidiary of American Shared Hospital Services (NYSE American: AMS), a leading provider of creative financial and turnkey technology solutions for advanced radiosurgery and radiation oncology services, announced today that it has entered into an agreement with Lovelace Medical Center (LMC), Albuquerque, NM, to reload its Gamma Knife Icon with new Cobalt Sources, as well as install...

read more
Clubhouse Media Group, Inc. Announces Model Talia Mint Joins HoneyDrip.com

Clubhouse Media Group, Inc. Announces Model Talia Mint Joins HoneyDrip.com

LOS ANGELES, December 13, 2023 - Clubhouse Media Group, Inc. (OTC: CMGR) ("Clubhouse Media Group"), a social media firm and digital agency, today announced that model and social media influencer, Talia Mint, has joined HoneyDrip.com. Mint has a large following, boasting 185K+ followers on Instagram alone. Honeydrip.com is a digital platform designed and wholly owned by CMGR with a focus on the empowerment of creators. The site allows creators to connect and engage with fans and monetize...

read more
PRISM NEXT GEN TECH COMPANY SPOTLIGHT: THE GLIMPSE GROUP’S JOURNEY INTO THE FUTURE

PRISM NEXT GEN TECH COMPANY SPOTLIGHT: THE GLIMPSE GROUP’S JOURNEY INTO THE FUTURE

NEW YORK, NY, December 12, 2023 - An immersive technology platform company, Glimpse recently announced its plans for a strategic shift from current immersive technologies that include virtual-reality headsets, tablets and phones to spatial computing, cloud and AI-driven immersive software solutions. From cutting-edge software development to immersive content creation, Glimpse pushes the boundaries of what is possible in the realm of extended realities....

read more
PRISM NEXT GEN TECH COMPANY SPOTLIGHT: THE GLIMPSE GROUP’S JOURNEY INTO THE FUTURE

PRISM MarketView Launches Emerging AdTech and Media Index

Leading global companies work to strike balance between digital and traditional advertising Industry experts point to 2H 2024 for AdTech and Media IPO market to strengthen NEW YORK, NY, December 12, 2023 - PRISM MarketView, a leading provider of unbiased market insight and company news, today announces the launch of its PRISM Emerging AdTech and Media Index. With a finger on the pulse of the digital media revolution, the PRISM index is tracking emerging companies making a mark on the adtech...

read more

Contact Us

PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850